PDGFRA and lipodystrophy: Our results suggest that adding MCP-1 to PRP may provide a valuable therapeutic approach to increase fat graft survival and adipogenesis in lipodystrophy patients by increasing PDGFRα and decreasing IL-10 expression of adipose tissue.